Known in the industry as the “Alpha Scientist,” Dr. Allen is in the forefront of scientific breakthroughs, including Nanotechnology, NanoMolecules, Quantum Chocolate, Genetic polymorphisms in Dysregulated Arginine Metabolism, Sickle Cell Polymorphisms, Thalassemia, Blind Amino Acid Riders, L-Arginine Isoform Pathways, and Edible Computer Chips.

The medical and research community states that Dr. Allen's science and technology is "Twenty years ahead of everyone else."

Known in the industry for her bold stance of setting high standards in scientific accuracy, Dr. Allen went so far as to correct Discover magazine, whose educational publication is considered the gold standard in science. Her statement on quaternary saturated amines prompted a correction by Discover.

For over twenty years, Dr. Allen had warned of the dangers of using L-arginine without a Blind Amino Acid Rider. Her stance on L-arginine was validated in January 2006, when the Journal of the American Medical Association (JAMA) published the Johns Hopkins clinical trial on oral L-arginine, in which L-arginine was shown to cause death in a significant segment of the subjects, which prompted the close of the clinical trial. (www.ArginineAnswers.com)

As a result of her long-term research on the amino acid L-arginine, the medical and scientific community refered to Dr. Allen as the Leader in L-Arginine Biochemistry, and the Queen of Arginine. The Biology Dictionary selected Dr. Allen’s definition of L-arginine as their standard.
(www.biology-online.org/dictionary/Arginine)

When Dr. Allen was asked by the media how she is able to stay on the leading edge of future-science, she replied:

“Part science, part skill, and part intuition. I also credit my savant-dyslexia. A dyslexic’s nonlinear images allows them to think much more quickly and multi-dimensionally. Albert Einstein was savant-dyslexic. Einstein was able to develop his theory of relativity due to his dyslexic properties of creativity and ability to make intuitive leaps. Intuitive leaps allow me to ignore conventional science and make theoretical bonds with nutritional concepts. The key then, is to scientifically prove these concepts.”

As a tribute to Einstein, in 1983 Dr. Allen named her L-Arginine Isoform Pathway L-Arginine M².

A group of top scientists, named “The Dream Team” have discovered the Key Code to a new treatment for Sickle Cell Disease and Thalassemia, the number one genetic disease in the world.

Fellow researchers named the group The Dream Team due to their groundbreaking research and discoveries in the field of NutraGenomics.

Touted globally as one of the most important discoveries of this century, researchers say that “This discovery may well be worthy of the Nobel Prize in Medicine.”

Clair Francomano, M.D.
•	Former Chief of Medical Genetics at the National Institutes of Health (NIH)
•	Former Clinical Director, National Human Genome Research Institute
•	Former Chief of Human Genetics for the Laboratory of Genetics at the National Institute on Aging
•	Fellowship in Medical Genetics, Johns Hopkins University School of Medicine
•	Associate Professor, Johns Hopkins University School of Medicine

Dr. Ann de Wees Allen
•	Chief of Biomedical Research at the Glycemic Research Institute in Washington, D.C.,
•	Named the World’s Leading L-Arginine Researcher
•	Received the first Glycemic Patent ever awarded
•	Discovered that L-Arginine is a Blind Amino Acid ®
•	Receiving another Patent for L-Arginine biochemistry
•	25-years of research in the field of L-Arginine biochemistry
•	Conducts Human In Vivo Clinical Trials for the U.S. Government, as well as the largest food companies in the world, including Proctor & Gamble and Hershey Foods,
•	Who’s Who of American Inventors

Randall Maxey, M.D., PhD.
•	Renowned Cardiologist and Nephrologist
•	Specialist in Renal disease in African Americans
•	F ormer President of the National Medical Association
•	PhD in Cardiovascular Pharmacology
•	Outstanding Alumni
•	Dean’s Special Service Award, Howard University, 2006
•	Lifetime Achievement Award, Washington D.C.
•	Who’s Who Among Black Americans
•	President, Alliance of Minority Medical Associations
•	Chief of Medicine, Encode Research Foundation for Ethnic-Related Diseases

Dr. Ann de Wees Allen’s amazing story of survival and her determination to live. From an athletic 115 pounds to a 78 pound skeleton, Dr. Allen fought to live after being given less than 2 % chance of survival from an aggressive and deadly cancer.

As the youngest person ever diagnosed with terminal stomach and esophageal cancer, and the only long-term survivor of this disease, Dr. Allen’s amazing quest for survival led her to a new path in her life; a life dedicated to science.

LINEAGE of the DE WEES ROYAL FAMILY OF ENGLAND

Descendants of King John I of England
History of the Royal Families of England